Journals / 7tepe Klinik / 2021 / Cilt: 17 - Sayı: 3

Anti-inflammatory effects of arctiin in a rat model of lipopolysaccaharideinduced periodontal disease: A pilot study

Arctiin maddesinin lipopolisakkarit indüklü periodontal hastalık modeli üzerindeki antienflamatuvar etkinliğinin incelenmesi: Pilot çalışma

Pages
183–189
Publication Date
2022-09-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Arctiin was shown to reduce pro-inflammatory cytokine levels in gingival tissues of rats with LPS-induced periodontitis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Arctiin has been shown to inhibit inflammatory processes in various tissues, but its effects on periodontium have yet to be examined.
📊
Key Findings & Data:Materials and Method: The study was conducted with 30 male Sprague-Dawley rats.
💡
Conclusion & Impact:Conclusion: Arctiin was shown to reduce pro-inflammatory cytokine levels in gingival tissues of rats with LPS-induced periodontitis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Arctiin has been shown to inhibit inflammatory processes in various tissues, but its effects on periodontium have yet to be examined. Therefore, the aim of this study was to evaluate whether arctiin reduces pro-inflammatory cytokine levels in gingival tissues of rats with periodontal disease. Materials and Method: The study was conducted with 30 male Sprague-Dawley rats. Experimental periodontal disease was induced by injecting lipopolysaccharide (LPS) between the first and second left maxillary molar teeth of rats, except control group (n=10). Experimental rats were randomly divided into two groups (Group EP: Experimental placebo-Dimethyl sulphoxide (DMSO); Group EA: Experimental Arctiin, n=10 each). Oral gavage carried out once per day for 21 days. All animals were then euthanized, gingival samples were obtained, and interleukin-1ß (IL-1ß) and tumor necrosis factor-a (TNF-a) were analysed by ELISA. Results: Gingival tissue IL-1ß and TNF-a levels were significantly lower in the Control Group compared to both experimental groups (EP and EA) (P<0.001). EA group presented lower pro-inflammatory cytokine levels than those of non-arctiin treated placebo group (P<0.001). Conclusion: Arctiin was shown to reduce pro-inflammatory cytokine levels in gingival tissues of rats with LPS-induced periodontitis.

Özet

Amaç: Arctiin maddesinin birçok dokuda enflamasyonu inhibe ettiği gösterilmiştir ancak bu etkilerin periodontal dokularda da olup olmadığı araştırılmamıştır. Bu çalışmanın amacı arctiin maddesinin periodontal hastalıklı rat gingival dokularında pro-enflamatuvar sitokin seviyelerinde bir azalmaya neden olup olmadığını incelemektir. Gereç ve Yöntem: Çalışma 30 adet erkek Sprague-Dawley sıçan ile yapıldı. Deneysel periodontal hastalık, kontrol grubu (n = 10) hariç, sıçanların birinci ve ikinci sol maksiller azı dişleri arasına lipopolisakkarit (LPS) enjekte edilerek oluşturuldu. Deney gruptaki sıçanlar rastgele iki gruba ayrıldı (Grup DP: Deneysel plasebo-Dimetil sülfoksit (DMSO); Grup DA: Deneysel Arctiin, herbiri n = 10). 21 gün boyunca günde bir kez ağızdan gavaj yapıldı. Daha sonra tüm hayvanlara ötenazi uygulandı, dişeti örnekleri alındı ve interleukin-1ß (IL-1 ß) ve tümör nekroz faktörü- a (TNF-a) ELISA ile analiz edildi. Bulgular: Kontrol grubu, deney grupları (Grup DP ve DA) ile karşılaştırıldığında diş eti dokusuna, IL-1ß ve TNF-a seviyeleri kontrol grubunda istatistiksel olarak anlamlı düzeyde az bulundu (P<0,001). DA grubu ise DP grubuna göre istatistiksel olarak daha düşük seviyelerde pro-enflamatuvar sitokin seviyeleri gösterdi (P<0,001). Sonuç: Arctiin maddesinin, LPS ile indüklenmiş periodontitisli sıçanların gingival dokularında proinflamatuar sitokin düzeylerini düşürdüğü gösterilmiştir.

🔖

Cite This Article

Aydoğdu, A., Acarel, E. E., Alaçam, H. (2022). Anti-inflammatory effects of arctiin in a rat model of lipopolysaccaharideinduced periodontal disease: A pilot study. 7tepe Klinik, Cilt: 17 - Sayı: 3, 183–189. https://ajindex.com/articles/426036

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Armitage GC. Development of a classification system for periodontal diseases and conditions. Annals of Periodontol 1999;4:1-6
  2. CHO MI, Garant PR. Development and general structure of the periodontium. Periodontol 2000. 2000;24:9- 27
  3. Page R. Current understanding of the aetiology and progression of periodontal disease. Int Dent J 1986;36:153- 161
  4. Socransky S, Haffajee A, Cugini M, Smith C, Kent Jr R. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-144
  5. Reddy MS, Geurs NC, Jeffcoat RL, Proskin H, Jeffcoat MK. Periodontal Disease Progression. J Periodontol 2000;71:1583-1590
  6. Schenkein HA. Host responses in maintaining periodontal health and determining periodontal disease. Periodontol 2000 2006;40:77-93
  7. Kantarci A, Hasturk H, Van Dyke TE. Host-mediated resolution of inflammation in periodontal diseases. Periodontol 2000 2006;40:144-163
  8. Kirkwood KL, Cirelli JA, Rogers JE, Giannobile WV. Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000 2007;43:294-315
  9. Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol 1996;1:821-878
  10. Souza JACd, Junior CR, Garlet GP, Nogueira AVB, Cirelli JA. Modulation of host cell signaling pathways as a therapeutic approach in periodontal disease. Journal of Applied Oral Science 2012;20:128-138
  11. Gemmell E, Marshall RI, Seymour GJ. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontology 2000 1997;14:112-143
  12. Lamster IB, Novak MJ. Host mediators in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. Crit Rev Oral Biol Med 1992;3:31-60
  13. Okada H, Murakami S. Cytokine expression in peri-odontal health and disease. Crit Rev Oral Biol Med 1998;9:248-266
  14. Salvi G, Lang N. The effects of non-steroidal anti- inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. Curr Pharm Des 2005;11:1757-1769
  15. Botelho M, Rao V, Carvalho C, Bezerra-Filho J, Fonseca S, et al. Lippia sidoides and Myracrodruon urundeuva gel prevents alveolar bone resorption in experimental periodontitis in rats. J Ethnopharmacol 2007;113:471- 478
  16. Cao CF, Sun XP. Herbal medicine for periodontal diseases. Int Dent J 1998;48:316-321
  17. Chan Y, Lai C-H, Yang H-W, Lin Y-Y, Chan C-H. The evaluation of Chinese herbal medicine effectiveness on periodontal pathogens. The Am J Chinese Med 2003;31:751-761
  18. Sastravaha G, Gassm